Michigan Healthcare Professionals PC

Michigan Healthcare Professionals PC was paid $106.17M by Medicaid between Jan 2018 and Dec 2024, across 513 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.

33Billing provider infoMICHIGAN HEALTHCARE PROFESSIONALS PC
FARMINGTON HILLS, MI 48334

33aNPI1295023547assigned 07/20/2011

33bProvider typeNeuromusculoskeletal Medicine & OMM Physician

28Total paid$106.17M

24GClaims1,963,295

24DCodes billed513

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Neuromusculoskeletal Medicine & OMM Physician providers in Michigan

Rank by total paid#1 of 14

Median peer was paid$1.22M

This provider vs. median87×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	247,021	$10.01M
2019	243,867	$10.38M
2020	226,633	$10.16M
2021	277,862	$13.46M
2022	318,246	$19.97M
2023	350,660	$22.99M
2024incomplete	299,006	$19.21M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	22%	314,885	257,581	$22.94M
J9271	Injection, pembrolizumab, 1 mg	17%	2,404	1,876	$18.02M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	7.4%	161,589	144,904	$7.81M
99232	Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity	3.8%	102,428	31,482	$4.01M
J0897	Injection, denosumab, 1 mg	3.6%	2,830	2,669	$3.78M
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	3.5%	40,096	39,753	$3.72M
J2505	Injection, pegfilgrastim, 6 mg	3.2%	1,348	984	$3.36M
99223	Prolong inpt eval add15 m	2.9%	30,342	26,599	$3.09M
J9299	Injection, nivolumab, 1 mg	2.7%	487	346	$2.85M
99233	Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m	1.6%	28,622	12,525	$1.69M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	1.4%	17,849	16,706	$1.53M
J9022	Injection, atezolizumab, 10 mg	1.3%	201	151	$1.40M

501 more codes

99203	Doctor's office visit, new patient (routine)	1.3%	22,300	$1.38M
99205	Prolong outpt/office vis	1.3%	11,992	$1.38M
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	1.3%	14,370	$1.34M
17110		1.2%	23,932	$1.23M
99222	Initial hospital care, per day, moderate complexity	1.1%	16,677	$1.18M
J9173	Injection, durvalumab, 10 mg	1.1%	190	$1.16M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	20,539	$958K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	10,257	$863K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	306	$859K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	2,998	$754K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	978	$731K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	575	$636K
10040		<1%	10,030	$634K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	2,339	$628K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	888	$583K
52000		<1%	5,391	$559K
59426		<1%	450	$409K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	7,923	$406K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	656	$366K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	68,554	$360K
Q5116	Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg	<1%	313	$360K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	5,660	$359K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	12,138	$356K
52356		<1%	1,556	$349K
59409	Vaginal delivery only (with or without episiotomy and/or forceps)	<1%	447	$332K
99385		<1%	3,223	$314K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	2,975	$299K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	10,019	$273K
J9306	Injection, pertuzumab, 1 mg	<1%	67	$271K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	42,392	$268K
99239	Hospital discharge day management, more than 30 minutes	<1%	4,486	$258K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	668	$256K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	250	$254K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	8,743	$253K
47562		<1%	683	$253K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	11,068	$250K
99386		<1%	2,131	$240K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	2,041	$231K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	<1%	120	$230K
93000		<1%	29,360	$222K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,863	$218K
59025	Fetal non-stress test	<1%	7,342	$203K
99238	Hospital discharge day management, 30 minutes or less	<1%	5,068	$201K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,543	$200K
96367		<1%	11,298	$190K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,762	$183K
96417		<1%	6,435	$180K
80047		<1%	21,170	$170K
99220		<1%	1,827	$169K
10060		<1%	2,412	$168K
52310		<1%	1,197	$168K
52332		<1%	2,087	$151K
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	58	$148K
36415	Collection of venous blood by venipuncture	<1%	55,059	$147K
52352		<1%	1,161	$140K
71046	Radiologic examination, chest; 2 views	<1%	8,753	$136K
96375	Therapeutic injection; each additional sequential IV push	<1%	14,064	$133K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	28,371	$130K
J9035	Injection, bevacizumab, 10 mg	<1%	82	$130K
J1453	Injection, fosaprepitant, 1 mg	<1%	3,113	$126K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	644	$121K
93458		<1%	973	$118K
43235		<1%	2,134	$116K
96416		<1%	1,696	$115K
59430		<1%	489	$112K
76872		<1%	1,520	$111K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	810	$111K
51728		<1%	802	$110K
51798		<1%	18,457	$108K
J1756	Injection, iron sucrose, 1 mg	<1%	2,831	$105K
99442		<1%	2,540	$101K
76801		<1%	1,481	$99K
81003		<1%	57,177	$93K
76818		<1%	1,288	$90K
90838		<1%	1,538	$89K
50590		<1%	282	$88K
99219		<1%	1,303	$88K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,631	$87K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	4,421	$86K
80305		<1%	10,234	$85K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	9,046	$85K
31575		<1%	1,276	$83K
11901		<1%	3,473	$83K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,945	$82K
96411		<1%	3,622	$81K
99496		<1%	738	$80K
94060		<1%	3,390	$79K
99495		<1%	908	$76K
76770		<1%	1,343	$76K
99195		<1%	1,354	$75K
99284	Emergency room visit (serious)	<1%	1,220	$74K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	5,115	$73K
90837	Psychotherapy session, about an hour	<1%	975	$73K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	697	$73K
99441		<1%	2,642	$71K
11102		<1%	1,377	$68K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	5,044	$67K
55700		<1%	637	$66K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	991	$66K
88112		<1%	2,190	$61K
76830	Ultrasound, transvaginal	<1%	872	$61K
17004		<1%	682	$58K
90682		<1%	973	$58K
96402		<1%	4,125	$57K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	905	$54K
99443		<1%	1,011	$53K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	376	$53K
J0185	Injection, aprepitant, 1 mg	<1%	252	$50K
99221		<1%	1,001	$49K
96415		<1%	4,125	$49K
99254		<1%	544	$48K
95115		<1%	9,326	$48K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,376	$45K
20610		<1%	2,979	$44K
90674		<1%	1,821	$44K
17000		<1%	2,032	$44K
51700		<1%	1,294	$43K
92557		<1%	2,039	$42K
90756		<1%	2,038	$42K
76813		<1%	618	$42K
76820		<1%	1,503	$39K
J9070	Cyclophosphamide, 100 mg	<1%	336	$39K
76825		<1%	258	$39K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	2,311	$38K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	359	$37K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	281	$37K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	157	$36K
J9190	Injection, fluorouracil, 500 mg	<1%	4,608	$34K
52005		<1%	772	$34K
99490	Ccm add 20min	<1%	2,598	$34K
96401		<1%	1,137	$34K
59514		<1%	40	$34K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	3,481	$33K
94729		<1%	1,277	$33K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	181	$32K
94726		<1%	1,257	$31K
69210		<1%	1,415	$31K
J9045	Injection, carboplatin, 50 mg	<1%	1,920	$30K
93298		<1%	1,567	$30K
99406		<1%	4,717	$29K
99217		<1%	815	$28K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	790	$28K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	567	$28K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	579	$26K
74420		<1%	1,986	$25K
J3489	Injection, zoledronic acid, 1 mg	<1%	1,105	$24K
99255		<1%	213	$24K
17003		<1%	1,332	$23K
92567		<1%	2,565	$22K
81002		<1%	10,515	$21K
99497		<1%	1,090	$20K
88121		<1%	88	$20K
J9041	Injection, bortezomib, 0.1 mg	<1%	463	$20K
93356		<1%	1,956	$20K
90688		<1%	1,177	$20K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,293	$19K
94750		<1%	426	$19K
81025		<1%	3,017	$19K
96368		<1%	2,689	$19K
J9267	Injection, paclitaxel, 1 mg	<1%	1,361	$19K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	241	$18K
99000		<1%	3,502	$18K
99283	Emergency room visit (moderate)	<1%	439	$17K
93015		<1%	667	$17K
76942		<1%	840	$17K
72110		<1%	700	$16K
96127		<1%	5,872	$16K
J9395	Injection, fulvestrant, 25 mg	<1%	102	$15K
30520		<1%	40	$15K
90686		<1%	900	$15K
54150		<1%	241	$14K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	454	$14K
82962		<1%	6,411	$14K
51705		<1%	324	$13K
81000		<1%	5,217	$13K
94010		<1%	816	$13K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	3,528	$13K
92928		<1%	51	$13K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	13,024	$13K
93299		<1%	237	$13K
99152		<1%	1,884	$12K
73030		<1%	870	$12K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	902	$12K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	13,569	$12K
99407		<1%	895	$12K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	412	$12K
64615		<1%	216	$12K
51797		<1%	170	$12K
76857		<1%	545	$11K
0001A		<1%	309	$11K
0002A		<1%	287	$11K
90834	Psychotherapy session, about 45 minutes	<1%	247	$11K
51702		<1%	372	$11K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	1,304	$10K
73630		<1%	564	$10K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,581	$10K
J2785	Injection, regadenoson, 0.1 mg	<1%	99	$10K
93351		<1%	170	$10K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	111	$10K
80053	Comprehensive metabolic panel	<1%	1,315	$9K
90715		<1%	298	$9K
92552		<1%	533	$9K
11900		<1%	274	$9K
82247		<1%	4,027	$9K
93308		<1%	513	$8K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	2,310	$8K
J3490	Unclassified drugs	<1%	2,512	$8K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	113	$8K
90836		<1%	179	$8K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	316	$8K
90670		<1%	54	$7K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	6,467	$7K
92555		<1%	543	$7K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	399	$7K
14040		<1%	29	$7K
99225		<1%	654	$7K
11103		<1%	177	$7K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	6,602	$7K
99308	Subsequent nursing facility care, per day, straightforward	<1%	248	$7K
54161		<1%	89	$7K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	74	$6K
96377		<1%	936	$6K
G0008	Administration of influenza virus vaccine	<1%	2,019	$6K
J9171	Injection, docetaxel, 1 mg	<1%	126	$6K
90732		<1%	89	$6K
99235		<1%	65	$6K
93325		<1%	858	$6K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	16	$6K
92550		<1%	454	$5K
90673		<1%	85	$5K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	454	$5K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	2,199	$5K
93018		<1%	694	$5K
0012A		<1%	133	$5K
96160		<1%	1,958	$5K
52351		<1%	33	$4K
73560		<1%	288	$4K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	355	$4K
76000		<1%	827	$4K
51741		<1%	929	$4K
95806		<1%	95	$4K
0011A		<1%	123	$4K
92540		<1%	68	$4K
76819	Fetal biophysical profile; without non-stress testing	<1%	93	$4K
58300		<1%	57	$4K
99218		<1%	119	$4K
92587		<1%	873	$4K
0031A		<1%	105	$4K
J9206	Injection, irinotecan, 20 mg	<1%	398	$4K
80061	Lipid panel	<1%	502	$3K
93295		<1%	171	$3K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	312	$3K
51784		<1%	184	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	650	$3K
99201		<1%	122	$3K
95816		<1%	27	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,906	$3K
96523		<1%	209	$3K
0004A		<1%	86	$3K
92941		<1%	12	$3K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	523	$3K
90662		<1%	455	$3K
93296		<1%	257	$3K
49650		<1%	14	$3K
84153		<1%	156	$3K
85651		<1%	1,429	$3K
73562		<1%	139	$3K
93297		<1%	69	$2K
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	923	$2K
90677		<1%	13	$2K
J2010	Injection, lincomycin hcl, up to 300 mg	<1%	315	$2K
76775		<1%	81	$2K
99234		<1%	30	$2K
90661		<1%	73	$2K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	41	$2K
73130		<1%	151	$2K
93312		<1%	38	$2K
11308		<1%	29	$2K
55250		<1%	12	$2K
99306	Prolong nursin fac eval 15m	<1%	22	$2K
11402		<1%	27	$2K
85060		<1%	176	$2K
90658		<1%	177	$2K
51720		<1%	114	$2K
93248		<1%	141	$2K
95811		<1%	14	$2K
95251		<1%	112	$2K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	25	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	27	$2K
G0180	Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care	<1%	180	$2K
99051		<1%	446	$2K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	121	$2K
90472	Immunization administration, each additional vaccine (list separately)	<1%	177	$2K
73502		<1%	97	$2K
82947		<1%	622	$2K
87086	Culture, bacterial; quantitative colony count, urine	<1%	379	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	809	$2K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	25	$2K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	52	$2K
64450		<1%	141	$2K
82570		<1%	514	$2K
91320		<1%	30	$2K
0134A		<1%	52	$1K
J7030	Infusion, normal saline solution , 1000 cc	<1%	807	$1K
77080		<1%	130	$1K
92015	Determination of refractive state	<1%	130	$1K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	207	$1K
82043		<1%	355	$1K
93320		<1%	96	$1K
90656		<1%	71	$1K
96409		<1%	38	$1K
93244		<1%	105	$1K
51610		<1%	55	$1K
99384		<1%	12	$1K
95024		<1%	13	$1K
64566		<1%	27	$1K
Q9991	Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg	<1%	225	$1K
92537		<1%	54	$1K
95117		<1%	151	$1K
11303		<1%	15	$1K
90694		<1%	214	$1K
0013A		<1%	30	$1K
Q2037	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)	<1%	77	$1K
85610		<1%	399	$1K
52281		<1%	13	$1K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	56	$1K
30901		<1%	12	$1K
93290		<1%	47	$989.29
11104		<1%	14	$979.02
54056		<1%	12	$939.18
0124A		<1%	38	$921.77
58301		<1%	15	$920.78
99224		<1%	186	$915.64
80076		<1%	272	$908.04
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	52	$904.11
92551		<1%	128	$903.86
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	51	$867.08
97750		<1%	204	$836.76
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	318	$831.91
J1071	Injection, testosterone cypionate, 1 mg	<1%	1,124	$794.35
G9008	Coordinated care fee, physician coordinated care oversight services	<1%	68	$754.87
99401		<1%	34	$731.50
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	14	$730.50
92978		<1%	16	$725.46
99310	Prolong nursin fac eval 15m	<1%	16	$712.96
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	2,686	$683.72
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	143	$660.91
93246		<1%	107	$659.34
90480		<1%	42	$634.52
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,310	$616.69
0003A		<1%	16	$614.69
11721		<1%	28	$614.06
74018		<1%	37	$598.74
87077		<1%	106	$589.88
94664		<1%	151	$581.85
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	55	$575.00
92625		<1%	14	$566.08
87088		<1%	92	$565.19
83735		<1%	130	$556.98
93242		<1%	85	$548.61
99305		<1%	27	$526.98
83615		<1%	218	$516.49
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	113	$497.95
J0461	Injection, atropine sulfate, 0.01 mg	<1%	316	$495.40
93350		<1%	13	$494.64
99153	Mod sedat endo service >5yrs	<1%	380	$486.39
99451		<1%	26	$482.50
92553		<1%	25	$473.35
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	16	$453.36
G2058	Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)).	<1%	23	$448.65
76870		<1%	13	$436.74
84100		<1%	239	$435.89
84550		<1%	228	$420.84
82044		<1%	133	$420.23
J2315	Injection, naltrexone, depot form, 1 mg	<1%	354	$396.27
86580		<1%	90	$363.62
73110		<1%	19	$357.71
92250		<1%	17	$352.47
87186		<1%	47	$335.59
93922		<1%	13	$307.81
92547		<1%	69	$277.67
72100		<1%	15	$275.52
45330		<1%	12	$275.04
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	346	$252.60
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	25	$232.55
76376		<1%	53	$232.15
97802		<1%	526	$210.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	66	$184.91
J2060	Injection, lorazepam, 2 mg	<1%	486	$182.78
51701		<1%	12	$173.81
G0136	Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months	<1%	38	$146.90
G9007	Coordinated care fee, scheduled team conference	<1%	12	$144.06
36591		<1%	63	$113.12
G0403	Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report	<1%	21	$109.68
J3480	Injection, potassium chloride, per 2 meq	<1%	103	$102.98
G0444	Annual depression screening, 5 to 15 minutes	<1%	2,695	$96.52
G0009	Administration of pneumococcal vaccine	<1%	42	$89.18
90653		<1%	34	$83.49
3074F		<1%	50,923	$81.23
0296T		<1%	13	$73.82
Q2039	Influenza virus vaccine, not otherwise specified	<1%	15	$72.01
G0442	Annual alcohol misuse screening, 5 to 15 minutes	<1%	758	$66.67
3078F		<1%	40,788	$65.60
86689		<1%	12	$64.12
81001		<1%	25	$55.25
3079F		<1%	29,724	$54.00
93321		<1%	12	$41.60
82270		<1%	14	$29.32
3075F		<1%	16,270	$28.87
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	15	$26.38
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	92	$25.31
94761		<1%	1,313	$25.00
1000F		<1%	7,248	$23.39
0298T		<1%	12	$21.51
3077F		<1%	13,013	$16.00
99072		<1%	5,931	$15.25
3008F		<1%	27,927	$12.42
4013F		<1%	3,662	$11.24
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	<1%	7,607	$6.02
G9275	Documentation that patient is a current non-tobacco user	<1%	6,507	$6.01
G8419	Bmi documented outside normal parameters, no follow-up plan documented, no reason given	<1%	1,824	$6.00
3080F		<1%	10,010	$5.76
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	4,482	$5.01
0502F		<1%	1,051	$1.38
4010F		<1%	3,561	$0.98
1160F		<1%	4,237	$0.32
2028F		<1%	243	$0.18
1159F		<1%	6,760	$0.16
G8420	Bmi is documented within normal parameters and no follow-up plan is required	<1%	4,231	$0.09
3051F		<1%	659	$0.08
1033F		<1%	1,302	$0.06
G9903	Patient screened for tobacco use and identified as a tobacco non-user	<1%	300	$0.06
G8752	Most recent systolic blood pressure < 140 mmhg	<1%	7,080	$0.05
G8754	Most recent diastolic blood pressure < 90 mmhg	<1%	8,425	$0.05
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	<1%	5,819	$0.02
4000F		<1%	419	$0.02
3052F		<1%	117	$0.02
G8482	Influenza immunization administered or previously received	<1%	151	$0.01
3044F		<1%	5,250	$0.01
3014F		<1%	54	$0.01
1170F		<1%	224	$0.01
G9906	Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)	<1%	13	$0.01
3046F		0%	495	$0.00
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	0%	704	$0.00
3725F		0%	672	$0.00
G8783	Normal blood pressure reading documented, follow-up not required	0%	389	$0.00
G8753	Most recent systolic blood pressure >= 140 mmhg	0%	3,639	$0.00
3288F		0%	58	$0.00
91300		0%	181	$0.00
3045F		0%	361	$0.00
91313		0%	46	$0.00
G9276	Documentation that patient is a current tobacco user	0%	265	$0.00
G8539	Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment	0%	32	$0.00
G8511	Screening for depression documented as positive, follow-up plan not documented, reason not given	0%	16	$0.00
99071		0%	429	$0.00
90611		0%	89	$0.00
3015F		0%	12	$0.00
4004F		0%	108	$0.00
G8730	Pain assessment documented as positive using a standardized tool and a follow-up plan is documented	0%	46	$0.00
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	0%	44	$0.00
3028F		0%	12	$0.00
99409		0%	40	$0.00
S9470	Nutritional counseling, dietitian visit	0%	40	$0.00
G8484	Influenza immunization was not administered, reason not given	0%	17	$0.00
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	0%	13	$0.00
2022F		0%	12	$0.00
3050F		0%	12	$0.00
G8418	Bmi is documented below normal parameters and a follow-up plan is documented	0%	1,748	$0.00
3017F		0%	320	$0.00
G8755	Most recent diastolic blood pressure >= 90 mmhg	0%	2,141	$0.00
G9664	Patients who are currently statin therapy users or received an order (prescription) for statin therapy	0%	170	$0.00
G8432	Depression screening not documented, reason not given	0%	4,951	$0.00
1036F		0%	3,026	$0.00
0500F		0%	488	$0.00
1111F		0%	189	$0.00
4086F		0%	4,431	$0.00
G9226	Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)	0%	65	$0.00
4011F		0%	2,520	$0.00
3048F		0%	98	$0.00
1123F		0%	180	$0.00
4008F		0%	2,259	$0.00
3351F		0%	470	$0.00
3353F		0%	43	$0.00
99024		0%	83	$0.00
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	0%	299	$0.00
1034F		0%	259	$0.00
G9189	Beta-blocker therapy prescribed or currently being taken	0%	57	$0.00
91301		0%	119	$0.00
3011F		0%	162	$0.00
2010F		0%	141	$0.00
91303		0%	40	$0.00
G9281	Screening performed and documentation that vaccination not indicated/patient refusal	0%	57	$0.00
Q3014	Telehealth originating site facility fee	0%	130	$0.00
1101F		0%	99	$0.00
1125F		0%	14	$0.00
G8428	Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given	0%	58	$0.00
1006F		0%	13	$0.00
3061F		0%	12	$0.00
36416		0%	13	$0.00
3352F		0%	16	$0.00
H0038	Self-help/peer services, per 15 minutes	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARGOLIS, JEFFREY (PRESIDENT)

Same official

Other billing entities under MARGOLIS, JEFFREY

Full network →

Provider	Location	Paid
American Oncologic Associates of Michigan, PC	Madison Heights, MI	$2.02M
Michigan Healthcare Professionals PC	Port Huron, MI	$193K
Michigan Healthcare Professionals	Southfield, MI	$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.